317 related articles for article (PubMed ID: 28128004)
21. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.
Dash PK; Kaminski R; Bella R; Su H; Mathews S; Ahooyi TM; Chen C; Mancuso P; Sariyer R; Ferrante P; Donadoni M; Robinson JA; Sillman B; Lin Z; Hilaire JR; Banoub M; Elango M; Gautam N; Mosley RL; Poluektova LY; McMillan J; Bade AN; Gorantla S; Sariyer IK; Burdo TH; Young WB; Amini S; Gordon J; Jacobson JM; Edagwa B; Khalili K; Gendelman HE
Nat Commun; 2019 Jul; 10(1):2753. PubMed ID: 31266936
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.
Roy U; McMillan J; Alnouti Y; Gautum N; Smith N; Balkundi S; Dash P; Gorantla S; Martinez-Skinner A; Meza J; Kanmogne G; Swindells S; Cohen SM; Mosley RL; Poluektova L; Gendelman HE
J Infect Dis; 2012 Nov; 206(10):1577-88. PubMed ID: 22811299
[TBL] [Abstract][Full Text] [Related]
23. Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages.
Araínga M; Guo D; Wiederin J; Ciborowski P; McMillan J; Gendelman HE
Retrovirology; 2015 Jan; 12():5. PubMed ID: 25608975
[TBL] [Abstract][Full Text] [Related]
24. Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.
Guo D; Zhou T; Araínga M; Palandri D; Gautam N; Bronich T; Alnouti Y; McMillan J; Edagwa B; Gendelman HE
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):e75-e83. PubMed ID: 27559685
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs.
Surve DH; Jindal AB
J Control Release; 2020 Aug; 324():379-404. PubMed ID: 32461114
[TBL] [Abstract][Full Text] [Related]
26. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
[TBL] [Abstract][Full Text] [Related]
27. Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals.
Zhou T; Lin Z; Puligujja P; Palandri D; Hilaire J; Araínga M; Smith N; Gautam N; McMillan J; Alnouti Y; Liu X; Edagwa B; Gendelman HE
Nanomedicine (Lond); 2018 Apr; 13(8):871-885. PubMed ID: 29553879
[TBL] [Abstract][Full Text] [Related]
28. Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs.
Herskovitz J; Hasan M; Machhi J; Mukadam I; Ottemann BM; Hilaire JR; Woldstad C; McMillan J; Liu Y; Seravalli J; Sarella A; Gendelman HE; Kevadiya BD
Nanotheranostics; 2021; 5(4):417-430. PubMed ID: 33972918
[No Abstract] [Full Text] [Related]
29. Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice.
Puligujja P; Araínga M; Dash P; Palandri D; Mosley RL; Gorantla S; Poluektova L; McMillan J; Gendelman HE
Antiviral Res; 2015 Aug; 120():85-8. PubMed ID: 26026666
[TBL] [Abstract][Full Text] [Related]
30. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
31. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
32. The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture.
Gendelman HE; McMillan J; Bade AN; Edagwa B; Kevadiya BD
Trends Microbiol; 2019 Jul; 27(7):593-606. PubMed ID: 30981593
[TBL] [Abstract][Full Text] [Related]
33. Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates.
Perazzolo S; Shireman LM; Koehn J; McConnachie LA; Kraft JC; Shen DD; Ho RJY
J Pharm Sci; 2018 Dec; 107(12):3153-3162. PubMed ID: 30121315
[TBL] [Abstract][Full Text] [Related]
34. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
Gao Y; Kraft JC; Yu D; Ho RJY
Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of a long-acting nanoformulated abacavir prodrug.
Singh D; McMillan J; Hilaire J; Gautam N; Palandri D; Alnouti Y; Gendelman HE; Edagwa B
Nanomedicine (Lond); 2016 Aug; 11(15):1913-27. PubMed ID: 27456759
[TBL] [Abstract][Full Text] [Related]
36. Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy.
Martinez-Skinner AL; Araínga MA; Puligujja P; Palandri DL; Baldridge HM; Edagwa BJ; McMillan JM; Mosley RL; Gendelman HE
PLoS One; 2015; 10(12):e0145966. PubMed ID: 26716700
[TBL] [Abstract][Full Text] [Related]
37. Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.
Balkundi S; Nowacek AS; Roy U; Martinez-Skinner A; McMillan J; Gendelman HE
J Vis Exp; 2010 Dec; (46):. PubMed ID: 21178968
[TBL] [Abstract][Full Text] [Related]
38. Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study.
Mandal S; Kang G; Prathipati PK; Fan W; Li Q; Destache CJ
Antiviral Res; 2018 Aug; 156():85-91. PubMed ID: 29885378
[TBL] [Abstract][Full Text] [Related]
39. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
40. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
